ArticleFrontiers in medicine2026

Combined treatment using repurposed synthetic peptide desmopressin and bevacizumab as a potential antiangiogenic strategy in osteosarcoma.

Luisina María Solernó et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.